Use of Tissue Plasminogen Activator (tPA) and Histidine-Tryptophan-Ketoglutarate Solution (HTK) in Donation after Circulatory Death (DCD) Liver Transplant Prevents Ischemic Cholangiopathy

Cabrales Arianna E.; Mangus Richard S.; Kubal Chandrashekhar A.

首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Use of Tissue Plasminogen Activator (tPA) and Histidine-Tryptophan-Ketoglutarate Solution (HTK) in Donation after Circulatory Death (DCD) Liver Transplant Prevents Ischemic Cholangiopathy

【24h】

Use of Tissue Plasminogen Activator (tPA) and Histidine-Tryptophan-Ketoglutarate Solution (HTK) in Donation after Circulatory Death (DCD) Liver Transplant Prevents Ischemic Cholangiopathy

机译：在循环死亡（DCD）肝移植后捐赠组织纤溶酶原激活剂（TPA）和组氨酸 - 色氨酸 - Ketoglutarate溶液（HTK）可防止缺血性胆管病

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transplantation: Official Journal of the Transplantation Society》 |2018年第9suppla期|共1页
作者
Cabrales Arianna E.; Mangus Richard S.; Kubal Chandrashekhar A.;
展开▼
作者单位

Indiana Univ Sch Med Dept Surg Transplant Div Indianapolis IN 46202 USA;

Indiana Univ Sch Med Dept Surg Transplant Div Indianapolis IN 46202 USA;

Indiana Univ Sch Med Dept Surg Transplant Div Indianapolis IN 46202 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类器官移植术;
关键词

相似文献

外文文献
中文文献
专利

1. Use of Tissue Plasminogen Activator (tPA) and Histidine-Tryptophan-Ketoglutarate Solution (HTK) in Donation after Circulatory Death (DCD) Liver Transplant Prevents Ischemic Cholangiopathy [J] . Cabrales Arianna E., Mangus Richard S., Kubal Chandrashekhar A. Transplantation: Official Journal of the Transplantation Society . 2018,第9Suppla期

机译：在循环死亡（DCD）肝移植后捐赠组织纤溶酶原激活剂（TPA）和组氨酸 - 色氨酸 - Ketoglutarate溶液（HTK）可防止缺血性胆管病
2. A literature-based cost analysis of tissue plasminogen activator for prevention of biliary stricture in donation after circulatory death liver transplantation [J] . J.M. Jones, N. Bhutiani, D. Wei, The American Journal of Surgery . 2018,第5期

机译：一种基于文献的组织纤溶酶原激活因子预防循环死亡肝移植术后胆道狭窄的成本分析
3. High-Dose Tissue Plasminogen Activator Flush in Donation-after-Cardiac-Death Donors May Mitigate Ischemic Biliary Strictures in Liver Transplantation [J] . Graham Jay, Lorenzen Katherine, Bellemare Sarah, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2017,第S2期

机译：在捐赠后心脏死亡供体中冲洗高剂量组织纤溶酶原激活剂可以减轻肝移植中的缺血性胆量狭窄
4. The Changes of Tissue-Type Plasminogen Activator and Matrix Metalloproteinases in Neonatal Mice with Hypoxic-Ischemic Encephalopathy [C] . Xu JianWen, Wang Wei, Zhao XiaoZhen, International Conference on Mechanical Engineering and Intelligent Systems . 2012

机译：缺氧缺血性脑病新生小鼠组织型纤溶酶原激活剂和基质金属蛋白酶的变化
5. A new role for tissue-type plasminogen activator in liver injury. [D] . Kang, Liang-I. 2013

机译：组织型纤溶酶原激活剂在肝损伤中的新作用。
6. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial [O] . Rianne van Rijn, Aad P. van den Berg, Joris I. Erdmann, 2019

机译：一项多中心随机对照试验的研究方案用于比较缺血性终末双重低温加氧机灌注与静态冷库在预防循环死亡后捐献的肝移植物移植后非解剖性胆道狭窄方面的功效：DHOPE-DCD试验
7. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival [O] . Christopher J. E. Watson, Fiona Hunt, Simon Messer, 2019

机译：在受控循环死亡捐赠中肝脏的原位常温灌注可能预防缺血性胆管病，并改善移植物生存
8. Tissue Plasminogen Activator (tPA) Mediates Neurotoxin-Induced Cell Death and Microglial Activation. [R] . Tsirka, S. E. 2001

机译：组织纤溶酶原激活物（tpa）介导神经毒素诱导的细胞死亡和小胶质细胞激活。

Use of Tissue Plasminogen Activator (tPA) and Histidine-Tryptophan-Ketoglutarate Solution (HTK) in Donation after Circulatory Death (DCD) Liver Transplant Prevents Ischemic Cholangiopathy

著录项

相似文献

相关主题

期刊订阅